Phase Genomics Secures $1.5M Gates Foundation Grant to Combat Methane from Cattle and Drug-Resistant Bacteria

Seattle biotech startup Phase Genomics received a $1.5 million grant from the Bill & Melinda Gates Foundation to research bacteriophage-based treatments targeting drug-resistant bacteria and methane-producing microbes in cows. The project aims to reduce methane emissions from cattle, a leading agricultural greenhouse gas source.